For greater levels of the TRAIL cytokine, we observed weak evidence of a detrimental effect (IVW: OR = 1.23 95% CI: 0.97 to 1.55, p = 0.07) on Alzheimer’s disease risk. This evidence concerns the gene TNFSF10 and early-onset autosomal dominant Alzheimer disease.